I don't disagree with your assessment. My point is what appears to be an inferior product with serious side effects in oncology after only 10 patients in phase 1, just got bought out for what would make cydy 10x return today. I am in no way suggesting we settle for that amount, but at the very least a 10x return should put a smile on anyone's face. That should be a bare minimum floor if all else fails type of thing. So 30 cents? Thank you sir may I have another.